Cisplatin Concept

subject area of

• N-Acetylcysteine Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting the C5a Receptor  Journal Articles
• A New Series of Succinimido-ferrociphenols and Related Heterocyclic Species Induce Strong Antiproliferative Effects, Especially against Ovarian Cancer Cells Resistant to Cisplatin  Journal Articles
• A Phase I Study of Pomalidomide (CC-4047) in Combination with Cisplatin and Etoposide in Patients with Extensive-Stage Small-Cell Lung Cancer  Journal Articles
• A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors  Journal Articles
• A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors  Journal Articles
• A combination of MSH2 DNA mismatch repair deficiency and expression of the SV40 large T antigen results in cisplatin resistance of mouse embryonic fibroblasts  Journal Articles
• A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers  Journal Articles
• A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancer  Journal Articles
• A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226  Journal Articles
• A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma  Journal Articles
• A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.  Journal Articles
• A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.  Journal Articles
• A pilot study using 99mTc to measure lead and platinum in the human kidney  Journal Articles
• A possible cellular mechanism of cisplatin-induced nephrotoxicity  Journal Articles
• A predictive index of cure versus no cure in advanced ovarian carcinoma patients—Replacement of second-look laparotomy as a diagnostic test  Journal Articles
• A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy  Journal Articles
• Addition of Pentoxifylline plus Nifedipine to Chemotherapy in Patients with Cisplatin-Resistant Cancers of the Lung and Other Sites  Journal Articles
• Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update  Journal Articles
• Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review  Journal Articles
• Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome  Journal Articles
• Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial  Journal Articles
• Adjuvant therapy for resected non-small-cell lung cancer: Past, present, and future  Journal Articles
• Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma  Journal Articles
• Advanced Ovarian Cancer: Phase III Randomized Study of Sequential Cisplatin–Topotecan and Carboplatin–Paclitaxel vs Carboplatin–Paclitaxel  Journal Articles
• Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines  Journal Articles
• Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line  Journal Articles
• Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression  Journal Articles
• Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer  Journal Articles
• Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer  Journal Articles
• Bax Homodimerization Is Not Required for Bax to Accelerate Chemotherapy-induced Cell Death  Journal Articles
• Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis  Journal Articles
• Better Treatments That Cost More: The Dilemma  Journal Articles
• Canadian Cancer Trials Group (CCTG) IND215: A phase Ib study of Selumetinib in patients with untreated advanced or metastatic NSCLC who are receiving standard chemotherapy regimens  Journal Articles
• Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.  Journal Articles
• Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline  Journal Articles
• Candidemia in women with breast carcinoma treated with high‐dose chemotherapy and autologous bone marrow transplantation  Journal Articles
• Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain  Journal Articles
• Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial  Journal Articles
• Chemotherapy agents and the induction of late lethal defects.  Journal Articles
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.  Journal Articles
• Chemotherapy for metastatic transitional carcinoma of the urinary tract:A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure  Journal Articles
• Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum-based combination  Journal Articles
• Chemotherapy with gemcitabine‐containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma  Journal Articles
• Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System  Journal Articles
• Choices of Methodology in Pharmacoeconomic Studies  Journal Articles
• Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin  Journal Articles
• Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy  Journal Articles
• Cisplatin-modification of DNA repair and ionizing radiation lethality in yeast, Saccharomyces cerevisiae  Journal Articles
• Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.  Journal Articles
• Combined chemotherapy and radiation therapy for non-small-cell lung cancer.  Journal Articles
• Combined gamma‐irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin  Journal Articles
• Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer:  Journal Articles
• Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer–a Meta-analysis  Journal Articles
• Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer  Journal Articles
• Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.  Journal Articles
• Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China  Journal Articles
• Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer.  Journal Articles
• Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer  Journal Articles
• Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.  Journal Articles
• Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodynamic therapy.  Journal Articles
• Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.  Journal Articles
• Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.  Journal Articles
• DIFFERENTIAL SENSITIVITY TO SHORT-CHAIN CERAMIDE ANALOGUES OF HUMAN INTESTINAL CARCINOMA CELLS GROWN IN TUMOR SPHEROIDS VERSUS MONOLAYER CULTURE  Journal Articles
• Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy  Journal Articles
• Differential Toxicity of Cis and Trans Isomers of Dichlorodiammineplatinum  Journal Articles
• Differential effects of cisplatin on mouse hepatic and renal mitochrondrial DNA  Journal Articles
• Drug-induced peripheral neuropathies.  Journal Articles
• Economic Analysis of NCIC CTG JBR.10: A Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared With Observation in Early Stage Non–Small-Cell Lung Cancer—A Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)  Journal Articles
• Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents.  Journal Articles
• Endodermal Sinus Tumor in Pregnancy  Journal Articles
• Energetic characteristics of cisplatin resistant ovarian carcinoma cells.  Journal Articles
• Epileptic seizures associated with cisplatin administration.  Journal Articles
• Ethical communication in clinical trials  Journal Articles
• Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.  Journal Articles
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conferences
• Evidence for lack of mitochondrial DNA repair followingcis-dichlorodiammineplatinum treatment  Journal Articles
• Exogenous estrogen therapy, testicular cancer, and the male to female transgender population: a case report  Journal Articles
• Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells  Journal Articles
• First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic Review  Journal Articles
• First-line therapy with VP-16 and cisplatin for small-cell lung cancer.  Journal Articles
• Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors  Journal Articles
• Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids  Journal Articles
• Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG  Journal Articles
• Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B‐cell non‐Hodgkin lymphoma  Journal Articles
• Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12  Journal Articles
• Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy  Journal Articles
• HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function  Journal Articles
• HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome  Journal Articles
• High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four cases  Journal Articles
• Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment  Journal Articles
• IL‐25 promotes cisplatin resistance of lung cancer cells by activating NF‐κB signaling pathway to increase of major vault protein  Journal Articles
• Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer  Journal Articles
• Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.  Journal Articles
• Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting  Journal Articles
• Increased BNip3 and decreased mutant p53 in cisplatin-sensitive PDT-resistant HT29 cells  Journal Articles
• Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck  Journal Articles
• Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)  Journal Articles
• Induction of Mdm2 and enhancement of cell survival by bFGF  Journal Articles
• Induction of micronucleated and binucleate cells in Chinese hamster ovary (CHO) cells by cis-diamminedichloroplatinum (II): a morphological and morphometric study  Journal Articles
• Influence of the proto-oncogene c-fos on cisplatin sensitivity  Journal Articles
• Inhibition of RNA polymerase II as a trigger for the p53 response  Journal Articles
• Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin  Journal Articles
• Initial Management of Small-Cell Lung Cancer (limited- and Extensive-Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy: A Systematic Review  Journal Articles
• Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer  Journal Articles
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells  Journal Articles
• Intra-Arterial Cisplatin for Bladder Cancer  Journal Articles
• Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol  Journal Articles
• Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.  Journal Articles
• Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes  Conferences
• MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function  Journal Articles
• Modulation of radiation-induced strand break repair by cisplatin in mammalian cells  Journal Articles
• Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy  Journal Articles
• Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression  Journal Articles
• NCIC CTG IND.190 Phase I Trial of Dalotuzumab (MK-0646) in Combination with Cisplatin and Etoposide in Extensive-Stage Small-Cell Lung Cancer  Journal Articles
• Naturally occurring resistance of bone marrow mononuclear and metastatic cancer cells to anticancer agents  Journal Articles
• Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance  Journal Articles
• Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer  Journal Articles
• Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)  Journal Articles
• Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration  Journal Articles
• Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site  Journal Articles
• PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop  Journal Articles
• Paclitaxel and cisplatin as intravesical agents against non‐muscle‐invasive bladder cancer  Journal Articles
• Paraspinal Synovial Sarcoma as an Unusual Postradiation Complication in Pediatric Abdominal Neuroblastoma  Journal Articles
• Patient preferences for oropharyngeal cancer treatment de‐escalation  Journal Articles
• Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument  Journal Articles
• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial  Journal Articles
• Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome  Journal Articles
• Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial  Journal Articles
• Phase I Study of Acivicin and Cisplatin in Non-Small-Cell Lung Cancer  Journal Articles
• Phase I Trial of Granulocyte-Macrophage Colony-Stimulating Factor With High-Dose Cisplatin and Etoposide for Treatment of Small-Cell Lung Cancer: A Study of the National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors  Journal Articles
• Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study  Conferences
• Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer  Journal Articles
• Phase II Study to Evaluate the Toxicity and Efficacy of Concurrent Cisplatin and Radiation Therapy in the Treatment of Patients with Locally Advanced Squamous Cell Carcinoma of the Cervix  Journal Articles
• Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.  Journal Articles
• Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma  Journal Articles
• Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.  Journal Articles
• Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.  Journal Articles
• Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma  Journal Articles
• Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.  Journal Articles
• Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer  Journal Articles
• Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy  Journal Articles
• Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment  Journal Articles
• Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer  Journal Articles
• Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)  Journal Articles
• Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.  Conferences
• Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12  Journal Articles
• Randomized Phase II Study of Gemcitabine Plus Cisplatin or Carboplatin, With or Without Cetuximab, As First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer  Conferences
• Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer  Conferences
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma  Journal Articles
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.  Journal Articles
• Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth  Journal Articles
• Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia  Journal Articles
• Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial  Journal Articles
• Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group  Journal Articles
• Roberts syndrome fibroblasts showing cisplatin hypersensitivity have normal host cell reactivation of cisplatin-treated adenovirus and normal capacity of cisplatin-treated cells for adenovirus DNA synthesis  Journal Articles
• Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy  Journal Articles
• Role of the transcription factor Ets-1 in cisplatin resistance  Journal Articles
• S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation  Journal Articles
• Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials  Journal Articles
• Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study  Journal Articles
• Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12  Journal Articles
• Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas  Journal Articles
• Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.  Journal Articles
• Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811  Conferences
• Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature  Journal Articles
• Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer  Journal Articles
• Surgical treatment for limited small-cell lung cancer  Journal Articles
• Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands  Journal Articles
• Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline  Journal Articles
• The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein  Journal Articles
• The Effect of Radiation and Cytotoxic Platinum Compounds on the Growth of Normal and Tumour Bladder Explant Cultures  Journal Articles
• The Effects of Cisplatin on Normal Human Erythrocytes in Vitro  Journal Articles
• The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer  Journal Articles
• The Transcriptional Coactivator Yes-Associated Protein Drives p73 Gene-Target Specificity in Response to DNA Damage  Journal Articles
• The Use of Chemotherapy in Patients with Advanced Malignant Pleural Mesothelioma: A Systematic Review and Practice Guideline  Journal Articles
• The Winged Helix Domain of CSB Regulates RNAPII Occupancy at Promoter Proximal Pause Sites  Journal Articles
• The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer  Journal Articles
• The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs  Journal Articles
• The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a canadian multicenter randomized trial  Journal Articles
• The effect of lonidamine alone and in combination with cisplatin on in vitro growth and viability of lung squamous cell carcinoma cell lines.  Journal Articles
• The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma  Journal Articles
• The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines.  Journal Articles
• The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway  Journal Articles
• The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.  Journal Articles
• The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.  Journal Articles
• Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy  Journal Articles
• Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.  Journal Articles
• Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer  Journal Articles
• Treatment of Small Cell Lung Cancer in the Elderly  Journal Articles
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol  Conferences
• Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in Children  Journal Articles
• Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer  Journal Articles
• UNEXPECTED MOBILISATION OF LEAD DURING CISPLATIN CHEMOTHERAPY  Journal Articles
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Journal Articles
• Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis  Journal Articles
• Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatin  Journal Articles
• Urine biomarkers of acute kidney injury in noncritically ill, hospitalized children treated with chemotherapy  Journal Articles
• Urothelial Bladder Cancer with Cavitary Lung Metastases  Journal Articles
• Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.  Journal Articles
• Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.  Journal Articles
• VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer  Journal Articles
• VP-16 and cisplatin as first-line therapy for small-cell lung cancer.  Journal Articles
• VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer  Journal Articles